Clinical Trials Directory

Trials / Completed

CompletedNCT05600283

Patient Self-sampling of HPV to Screen for Cervical Cancer

Validation and Feasibility of Patient Self-sampling of HPV for Cervical Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
222 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSwab kit (COBAS HPV 4800 Assay -Evalyn brush)Patient self-sampling swab kit to collect a vaginal sample for HPV testing
DIAGNOSTIC_TESTClinician-collection of cervical sample for HPV testingSpeculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)

Timeline

Start date
2022-11-16
Primary completion
2024-06-04
Completion
2024-06-04
First posted
2022-10-31
Last updated
2026-01-06
Results posted
2025-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05600283. Inclusion in this directory is not an endorsement.